Antioxidant activity of Oenanthe stolonifera D.C extract and AMPK activation on human liver cancer cells by anticancer effects

Abstract

The aim of this study was to investigate the anticancer effect of Oenanthe stolonifera D.C extract (OJE) on Hep3B, a human liver cancer cell, and identify the anticancer mechanisms. When treated with 1.0 mg/mL of OJE in HEK-293 and HEP3B to test the anticancer effect based on cell viability and mobility, the extract showed no growth inhibitory effect on HEK-293, while Hep3B's cell viability and mobility significantly decreased to 62.5% and 48.6%, respectively. The RNA expression levels of AMP-activated protein kinase (AMPK), protein-53 (p53), and cyclooxygenase-2 (COX-2), which are key genes of carcinogenesis, were examined to investigate the mechanism of the anticancer effect. OJE downregulated COX-2 and increased the expression of cancer suppressors AMPK and p53 in a concentration-dependent manner. HPLC analysis was conducted to quantify secondary metabolites in OJE, and 0.50 mg/g DM of chlorogenic acid was identified as the main substance. Therefore, Oenanthe stolonifera D.C containing bioactive substances is valuable as a natural source for anticancer agent in the food and pharmaceutical industries.

Keywords:
Oenanthe stolonifera D.C.; chlorogenic acid; Hep3B; AMPK; apoptosis; antioxidant; carcinogenesis; metastasis